Letermovir
Product
Information
use in prophylaxis of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell transplant patients. It is the first of a new class of CMV anti-infectives called DNA terminase complex inhibitors.
Distribution Areas
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)
Supplied From
China
